Brian Strauss

Brian joined Inari in April 2017. Brian has an extensive background in development of novel and disruptive medical device technologies in early stage companies, consistently resulting in value creation and successful exits. He has held senior executive positions in R&D, operations, and IP development. Prior to joining Inari, Brian was Chief Technology Officer at Reverse Medical, Inc. where he was responsible for developing neurovascular catheters and devices, one of which was sold to Covidien in 2012, the others of which were sold to Medtronic as part of their acquisition of Reverse in 2014. Brian remained at Medtronic as R&D Director of their neurovascular division responsible for embolization product development. Before Reverse Medical, Brian held management and engineering positions at ev3 (acquired by Covidien), Micro Therapeutics (acquired by ev3), and Gish Biomedical (acquired by Sorin Medical). Brian holds a B.S. in mechanical engineering from the University of California, Santa Barbara, and a Masters of Business Administration from California State University, Long Beach. Brian is a named inventor on over 50 issued U.S. and international patents.